Tislelizumab Plus Platinum and Etoposide vs Placebo Plus Platinum and Etoposide as the First-Line Treatment for Patients With Extensive–Stage SCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Tislelizumab Plus Platinum and Etoposide Versus Placebo Plus Platinum and Etoposide as First-Line Treatment for Extensive-Stage SCLC (RATIONALE-312): A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Phase 3 Clinical Trial
J Thorac Oncol 2024 Mar 07;[EPub Ahead of Print], Y Cheng, Y Fan, Y Zhao, D Huang, X Li, P Zhang, M Kang, N Yang, D Zhong, Z Wang, Y Yu, Y Zhang, J Zhao, T Qin, C Chen, S Leaw, W Zheng, Y SongFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.